Clifford Chance advised Yibin City Commercial Bank on the deal, King & Wood Mallesons advised the Joint Sponsors, and Underwriters counsel. Yibin City Commercial Bank completed...
Yibin Citi Commercial Bank’s HK$1.7 Billion IPO On HKEX
Xunfei Healthcare Technology’s $75 Million IPO On HKSE
Clifford Chance advised Xunfei Healthcare Technology Co., Ltd. DLA Piper advised joint sponsors Huatai Financial Holdings (Hong Kong) Limited, GF Capital (Hong Kong) Limited, CCB International...
Mao Geping Cosmetics’ $300 Million IPO On HKSE
Clifford Chance advised Mao Geping Cosmetics, while Paul Hastings advised the underwriters on the deal. Mao Geping Cosmetics completed its initial public offering and listing on...
China Resources Beverages Ltd’s $650 Million IPO On HKSE
Clifford Chance advised China Resources Beverages, while Paul Hastings advised the joint sponsors and the underwriters on the deal. China Resources Beverages completed its initial public...
Laopu Gold’s HK$906 Million HKEX IPO
On the deal, O’Melveny acted for Laopu Gold, Linklaters advised the underwriters. Laopu Gold Co., Ltd. completed the global offering and listing of H shares on...
Persistence Resources Group’s Initial Public Offering
Howse Williams acted as the legal adviser to the sole sponsor, the overall coordinator and the underwriters. Persistence Resources Group Ltd completed HK$275.0 million global offering and...
iMotion Automotive Technology’s HK$595.2 Million Initial Public Offering
Shearman & Sterling represented the joint sponsors and sponsor-overall coordinators in the offering. iMotion Automotive Technology (Suzhou) Co., Ltd. (iMotion) announced its initial public offering on The...
Beijing Fourth Paradigm Technology’s $150 Million Initial Public Offering
O’Melveny represented the sole sponsor, the coordinators and the underwriters in the transaction. Beijing Fourth Paradigm Technology Co., Ltd. (6682.HK) announced its initial public offering and listing...
Wuhan YZY Biopharma’s HK$176 Million Initial Public Offering
Cooley, Jingtian & Gongcheng and King & Wood Mallesons advised YZY Biopharma, while Sidley and Merits & Tree acted as legal counsel for the sole sponsor...
OrbusNeich Medical Group’s US$61.6 Million Initial Public Offering
Baker McKenzie advised the underwriters on the deal while O’Melveny represented OrbusNeich Medical Group. OrbusNeich Medical Group Holdings Limited (6929.HK) announced its approximate US$61.6 million (approximately HK$481...
OrbusNeich Medical Group’s Initial Public Offering
Baker McKenzie advised the underwriters on the deal. OrbusNeich Medical Group executed an initial public offering. OrbusNeich Medical is a major global medical device manufacturer specializing...
Huafang Group Inc.’s IPO
O’Melveny advised the sponsors and underwriters on the listing, while Wilson Sonsini Goodrich & Rosati and Maples and Calder represented Huafang. Huafang Group Inc. announced the IPO...